Wacław Weyde

Wacław Weyde

Auto-generated profile, based on publicly available information

Wacław Weyde

Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland; Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland; Fresenius Polska

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2015 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
TGTomasz Gołębiowski
Tomasz Gołębiowski
WWWacław Weyde
Wacław Weyde
MKMariusz Kusztal
Mariusz Kusztal
TPTomasz Porazko
Tomasz Porazko
HAHanna Augustyniak-Bartosik
Hanna Augustyniak-Bartosik
Marian KlingerMarian Klinger
Marian Klinger
Diabetics with stage V chronic kidney disease (CKD) on hemodialysis (HD) are considered as "difficult patients", because of problems with creation of the vascular access. There is controversy regarding the results and recommendations for preparation of the vascular access in these patients. The aim of this retrospective study was to evaluate the results of creating different types of arteriovenous fistula (AVFs) in consecutive series of patients starting dialysis treatment. The analysis was performed in 741 patients (385 females and 356 males), average age 61.4±7 years, who started dialysis treatment in our department between January 2005 and December 2012. Native AVFs were created in all patients. No patients received an AVF requiring synthetic graft material. The number of patients with diabetic nephropathy was 166 (22.4%). Among them, 30 (18%) had type 1 diabetes and 136 (82%) type 2. In this group the occurrence of calcification in the forearm artery was estimated on the basis of physical examination, Allan's test, Doppler ultrasound and forearm X-ray. In a subgroup of patients with atherosclerotic changes in the arterial system the frequency of failed AVFs was analyzed. These results were compared with the group without diabetes. The number of procedures necessary for successfu AVF creation and type of access was counted in both groups. The assessment of the procedure frequency and AVF location in diabetic and in non-diabetic patients was made by χ² test with Yates correction. In the group of 166 patients with diabetes, in 100 cases (60%) atherosclerotic changes in forearm arteries were observed. In a subgroup of 30 patients with type 1 diabetes atherosclerosis was observed in 17 adults (57%). In this subgroup creation of a suitable forearm AVF in the first procedure in 9 patients was possible and in the other 8 cases the atherosclerotic changes necessitated repeated procedures and were an important obstacle to create the AVF. In the subgroup of 136 patients with type 2 diabetes, atherosclerosis in the forearm artery was observed in 83 cases (61%). In this subgroup the creation of a native AVF was possible in 40 patients during the first procedure and in 43 cases additional intervention was needed, but only in 8 cases was atherosclerosis the cause of fistula failure. Generally, among 166 patients only in 16 cases (10%) did atherosclerosis present an important obstacle for AVF creation, but the number of necessary procedures to create one functioning AVF was significantly greater in this population (2 v 2.7, p=0.0001). A functioning AVF in patients with diabetes was found significantly frequently in the arm localization in comparison to non-diabetic patients (4.3 v 2%, p=0.0478). Atherosclerotic changes in forearm arteries in diabetic patients appear in 60% of hemodialysis patients and make it difficult to create an AVF only in 10% of diabetic patients, but it is possible to create a native AVF in 90% of diabetic patients, although this requires more procedures. In patients with diabetes, AVF in the wrist region should be preferred.

23 November 2015 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
KLKrzysztof Letachowicz
Krzysztof Letachowicz
KMKatarzyna Madziarska
Katarzyna Madziarska
WLWaldemar Letachowicz
Waldemar Letachowicz
MKMagdalena Krajewska
Magdalena Krajewska
JPJózef Penar
Józef Penar
Marian KlingerMarian Klinger
Marian Klinger

1 January 2008
Verified
Journal Article
Closed access
Mirosław BanasikMirosław Banasik
Mirosław Banasik
JKJakub Kuźniar
Jakub Kuźniar
MKMariusz Kusztal
Mariusz Kusztal
TPTomasz Porazko
Tomasz Porazko
WWWaclaw Weyde
Waclaw Weyde
Marian KlingerMarian Klinger
Marian Klinger

1 February 2003
Verified
Journal Article
Closed access
MKMariusz Kusztal
Mariusz Kusztal
KNKrzysztof Nowak
Krzysztof Nowak
MMMaria Magott-Procelewska
Maria Magott-Procelewska
WWWacław Weyde
Wacław Weyde
JPJózef Penar
Józef Penar

4 July 2014 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
JGJerzy Garcarek
Jerzy Garcarek
EWEwa Wątorek
Ewa Wątorek
JKJacek Kurcz
Jacek Kurcz
MKMariusz Kusztal
Mariusz Kusztal
TGTomasz Gołębiowski
Tomasz Gołębiowski
Marian KlingerMarian Klinger
Marian Klinger

28 June 2016 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
OROlumide Olatubosun Rowaiye
Olumide Olatubosun Rowaiye
MKMariusz Kusztal
Mariusz Kusztal
WWWacław Weyde
Wacław Weyde
Marian KlingerMarian Klinger
Marian Klinger
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of small vessel vasculitides which commonly affect the kidneys, manifesting as rapidly progressive glomerulonephritis. In this review, we present different treatment methods (e.g. cyclophosphamide, rituximab, plasma exchange) used for remission induction and maintenance in renal AAV. We also discuss treatment options in relapsing and refractory disease and for patients with end-stage renal disease due to AAV. In addition, we enumerate the various risk factors associated with relapsing and refractory disease, quality of life impairment and decreased renal and patient survival in AAV. Finally we present information on new, potentially applicable agents which can further help modify the disease course, thereby leading to increased patient survival.